Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
103
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

Patrizia Alvisi1 Pediatric Gastroenterology Unit, Pediatric Department, Maggiore Hospital, Bologna, Italy, [email protected]Correspondence[email protected]
,
Serena Arrigo2 Pediatric Gastroenterology and Endoscopy Unit, G Gaslini Children’s Hospital, Genoa, Italy
,
Salvatore Cucchiara3 Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy
,
Paolo Lionetti4 Gastroenterology and Nutrition Unit, Meyer Children’s Hospital, Florence, Italy
,
Erasmo Miele5 Pediatric Department, Federico II University of Naples, Naples, Italy
,
Claudio Romano6 Pediatric Gastroenterology, University of Messina, Messina, Italy
,
Alberto Ravelli7 Gastroenterology and GI Endoscopy Unit, University Department of Pediatrics, Children’s Hospital, Brescia, Italy
,
Daniela Knafelz8 Hepatology and Gastroenterology Unit, Bambino Gesù Hospital, Rome, Italy
,
Stefano Martelossi9 Department of Pediatrics, Institute of Child Health, IRCSS Burlo Garofolo, Trieste, Italy
,
Graziella Guariso10 University of Padua, Padua, Italy
,
Salvatore Accomando11 Pediatric Department, University of Palermo, G di Cristina Children’s Hospital, Palermo, Italy
,
Giovanna Zuin12 Pediatric Unit, Buzzi Hospital, Milan, Italy
,
Costantino De Giacomo13 Pediatric Unit, Niguarda Hospital, Milan, Italy
,
Lucio Balzani14 Morgagni Hospital, Forlì, Italy
,
Monia Gennari15 Emergency Pediatric Department, S Orsola Hospital, Bologna, Italy
,
Marina Aloi3 Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy
& On behalf of the SIGENP IBD Working Group show all
Pages 13-21 | Published online: 03 Jan 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Johanna Lehtomäki, Anne Nikkonen, Laura Merras-Salmio, Pauliina Hiltunen & Kaija-Leena Kolho. (2022) Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 57:1, pages 31-36.
Read now
James J Ashton, Zachary Green, Vinod Kolimarala & R Mark Beattie. (2019) Inflammatory bowel disease: long-term therapeutic challenges. Expert Review of Gastroenterology & Hepatology 13:11, pages 1049-1063.
Read now

Articles from other publishers (4)

So Yoon Choi & Ben Kang. (2022) Adalimumab in Pediatric Inflammatory Bowel Disease. Frontiers in Pediatrics 10.
Crossref
Laura Guberna, Olga P. Nyssen, María Chaparro & Javier P. Gisbert. (2021) Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis. Journal of Clinical Medicine 10:10, pages 2132.
Crossref
Marianna Lucafò, Debora Curci, Matteo Bramuzzo, Patrizia Alvisi, Stefano Martelossi, Tania Silvestri, Veronica Guastalla, Flavio Labriola, Gabriele Stocco & Giuliana Decorti. (2021) Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease. Frontiers in Pediatrics 9.
Crossref
Francesca Penagini, Lucia Cococcioni, Elena Pozzi, Dario Dilillo, Giulia Rendo, Cecilia Mantegazza & Gian Vincenzo Zuccotti. (2020) Biological therapy in pediatric age. Pharmacological Research 161, pages 105120.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.